Display options
Share it on

Mol Med. 2016 Dec;22:713-723. doi: 10.2119/molmed.2016.00041. Epub 2016 Sep 29.

RhoA/ROCK signaling regulates TGFβ-induced epithelial-mesenchymal transition of lens epithelial cells through MRTF-A.

Molecular medicine (Cambridge, Mass.)

Anna Korol, Aftab Taiyab, Judith A West-Mays

Affiliations

  1. Department of Pathology and Molecular Medicine, McMaster University Health Science Centre, Rm 4H25, 1200 Main St. West. Hamilton, ON, L8N 3Z5, Canada.

PMID: 27704140 PMCID: PMC5135079 DOI: 10.2119/molmed.2016.00041

Abstract

Transforming growth factor (TGF)-β-induced epithelial-mesenchymal transition (EMT) leads to the formation of ocular fibrotic pathologies, such as anterior subcapsular cataract and posterior capsule opacification. Remodeling of the actin cytoskeleton, mediated by the Rho family of GTPases, plays a key role in EMT, however, how actin dynamics affect downstream markers of EMT has not been fully determined. Our previous work suggests that myocardin related transcription factor A (MRTF-A), an actin-binding protein, might be an important mediator of TGFβ-induced EMT in lens epithelial cells. The aim of the current study was to determine the requirement of RhoA/ROCK signaling in mediating TGFβ-induced nuclear accumulation of MRTF-A, and ultimate expression of α-smooth muscle actin (αSMA), a marker of a contractile, myofibroblast phenotype. Using rat lens epithelial explants, we demonstrate that ROCK inhibition using Y-27632 prevents TGFβ-induced nuclear accumulation of MRTF-A, E-cadherin/β-catenin complex disassembly, and αSMA expression. Using a novel inhibitor specifically targeting MRTF-A signaling, CCG-203971, we further demonstrate the requirement of MRTF-A nuclear localization and activity in the induction of αSMA expression. Overall, our findings suggest that TGFβ-induced cytoskeletal reorganization through RhoA/ROCK/MRTF-A signaling is critical to EMT of lens epithelial cells.

Keywords: Cataract; beta catenin; cytoskeleton; fibrosis; myofibroblast

References

  1. Br J Ophthalmol. 2002 Feb;86(2):220-6 - PubMed
  2. Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3450-60 - PubMed
  3. Br J Ophthalmol. 2012 May;96(5):614-8 - PubMed
  4. J Cataract Refract Surg. 2010 Oct;36(10):1768-74 - PubMed
  5. Optometry. 2001 Feb;72(2):94-102 - PubMed
  6. Inflamm Bowel Dis. 2014 Jan;20(1):154-65 - PubMed
  7. PLoS One. 2013 Dec 10;8(12):e83188 - PubMed
  8. Dev Dyn. 2006 Jun;235(6):1589-98 - PubMed
  9. J Cell Sci. 2007 May 15;120(Pt 10):1801-9 - PubMed
  10. Mol Cancer Ther. 2007 Aug;6(8):2249-60 - PubMed
  11. Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5736-5747 - PubMed
  12. J Med Assoc Thai. 2006 Oct;89(10):1766-9 - PubMed
  13. Ophthalmology. 2010 Aug;117(8):1506-11 - PubMed
  14. Am J Physiol Renal Physiol. 2008 May;294(5):F1116-28 - PubMed
  15. Invest Ophthalmol Vis Sci. 2001 Apr;42(5):1029-37 - PubMed
  16. Nat Cell Biol. 2002 Jun;4(6):408-15 - PubMed
  17. Invest Ophthalmol Vis Sci. 1995 Jul;36(8):1709-13 - PubMed
  18. J Cell Physiol. 2015 Aug;230(8):1829-39 - PubMed
  19. Beilstein J Org Chem. 2013 May 21;9:966-73 - PubMed
  20. Cell. 2003 May 2;113(3):329-42 - PubMed
  21. Mol Biol Cell. 2001 Jan;12(1):27-36 - PubMed
  22. Cornea. 2014 Nov;33 Suppl 11:S25-31 - PubMed
  23. Am J Pathol. 2013 Feb;182(2):388-400 - PubMed
  24. Mol Biol Cell. 2007 Mar;18(3):1083-97 - PubMed
  25. Mol Reprod Dev. 2015 Jul-Aug;82(7-8):518-29 - PubMed
  26. Curr Eye Res. 2001 Jun;22(6):470-4 - PubMed
  27. Exp Eye Res. 2009 Feb;88(2):257-69 - PubMed
  28. Am J Physiol Heart Circ Physiol. 2007 Feb;292(2):H1170-80 - PubMed
  29. Invest Ophthalmol Vis Sci. 1998 Jul;39(8):1399-409 - PubMed
  30. Am J Pathol. 2006 Jan;168(1):69-79 - PubMed
  31. J Cell Sci. 2008 Apr 1;121(Pt 7):1025-35 - PubMed
  32. EMBO Rep. 2012 Oct;13(10):900-8 - PubMed
  33. Cell. 2014 Jan 30;156(3):563-76 - PubMed
  34. Am J Ophthalmol. 1983 Jan;95(1):82-96 - PubMed
  35. J Cell Biol. 2007 Dec 3;179(5):1027-42 - PubMed
  36. Am J Physiol Renal Physiol. 2003 May;284(5):F911-24 - PubMed
  37. Biochem J. 2000 Jun 1;348 Pt 2:241-55 - PubMed
  38. Ophthalmologe. 2009 Nov;106(11):1017-21 - PubMed
  39. Cell Biol Int. 2007 Oct;31(10):1225-30 - PubMed
  40. Invest Ophthalmol Vis Sci. 1998 Jul;39(8):1410-8 - PubMed
  41. Nature. 1997 Oct 30;389(6654):990-4 - PubMed
  42. Am J Physiol Cell Physiol. 2007 Jan;292(1):C70-81 - PubMed
  43. Am J Physiol Renal Physiol. 2003 Jul;285(1):F130-42 - PubMed
  44. Mol Vis. 2013 May 06;19:1017-28 - PubMed
  45. Diab Vasc Dis Res. 2016 Jan;13(1):81-92 - PubMed
  46. Am J Pathol. 2014 Jul;184(7):2001-12 - PubMed
  47. Exp Cell Res. 2014 Oct 15;328(1):164-71 - PubMed
  48. Invest Ophthalmol Vis Sci. 1991 Jul;32(8):2201-11 - PubMed
  49. Am J Pathol. 2004 Feb;164(2):651-63 - PubMed
  50. J Biol Chem. 2002 Mar 22;277(12):9800-5 - PubMed
  51. PLoS One. 2014 Feb 18;9(2):e89016 - PubMed
  52. Int J Mol Med. 2013 Aug;32(2):464-8 - PubMed
  53. Curr Eye Res. 1994 Dec;13(12):885-90 - PubMed
  54. Mol Vis. 2003 Jul 17;9:329-36 - PubMed
  55. Invest Ophthalmol Vis Sci. 2004 Jun;45(6):1946-53 - PubMed
  56. Nippon Ganka Gakkai Zasshi. 1994 May;98(5):495-500 - PubMed
  57. Acta Anat (Basel). 1984;119(2):106-12 - PubMed
  58. J Cell Biol. 2010 Jun 28;189(7):1107-15 - PubMed
  59. FEBS Lett. 2008 Jan 23;582(2):291-8 - PubMed
  60. Cells Tissues Organs. 2005;179(1-2):43-55 - PubMed
  61. Pharmacol Ther. 2013 Mar;137(3):352-64 - PubMed
  62. Integr Biol (Camb). 2015 Oct;7(10 ):1109-19 - PubMed
  63. Curr Med Chem. 2008;15(27):2876-85 - PubMed
  64. Mol Vis. 2007 Mar 27;13:457-69 - PubMed

Publication Types

Grant support